India Highlights 24 Week Ashwagandha Safety Trial Involving 1,200 Adults
Ashwagandha safety trial findings from India offer reassuring data on a standardized root extract used for 24 weeks in 1,200 adults. The study found no treatment-related serious liver or kidney injury, but mild liver enzyme elevations were still reported, making product quality, patient selection and medical supervision important.